Montes Archimedes Acquisition (ROIV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Research upped their Q1 2025 EPS estimates for Extra Space Storage in a report released on Monday, February 10th. Zacks ...

Equities research analysts at Zacks Research raised their Q2 2025 EPS estimates for shares of Synchrony Financial in a ...

PhenixFIN (PFX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Arvinas, Inc. (ARVN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

Pliant Therapeutics, Inc. (PLRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Dividend Fund earns an Average Process Pillar rating. The main driver of the rating is the firm's retention rate of the firm's portfolio managers, which is 100% over the timeframe for which ...

NEW YORK (AP) — NEW YORK (AP) — Moody's Corp. (MCO) on Thursday reported fourth-quarter profit of $395 million. On a per-share basis, the New York-based company said it had profit of $2.17. Earnings, ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The drugstore chain and pharmacy benefits manager earned $1.64 billion, or $1.30 ...